Skip to main content
Year archive

MorphoSys AG — 2020 filings

All 117 regulatory filings released by MorphoSys AG (MOR) in 2020, sourced directly from the official regulator.

117 Filings
2020 Period
2020 filings (117)
Filing Released Lang
Declaration of Voting Results & Voting Rights Announcements 2020
Declaration of Voting Results & Voting Rights Announcements
2020-12-28 English
MorphoSys AG: Corporate Calendar 2021
Report Publication Announcement
2020-12-17 English
Declaration of Voting Results & Voting Rights Announcements 2020
Declaration of Voting Results & Voting Rights Announcements
2020-12-10 English
Declaration of Voting Results & Voting Rights Announcements 2020
Declaration of Voting Results & Voting Rights Announcements
2020-12-09 English
Data Evaluating Tafasitamab with and without Lenalidomide in Combination with R-CHOP in Patients with DLBCL Presented at ASH 2020
Regulatory Filings
2020-12-07 English
MorphoSys' Licensee Announces Approval by the European Commission for Tremfya(R) (guselkumab) for Treatment of Adults with Active Psoriatic Arthritis (PsA)
Regulatory Filings
2020-12-02 English
Thomas Biegi Joins MorphoSys as Head of Corporate Communications
Board/Management Information
2020-12-01 English
Declaration of Voting Results & Voting Rights Announcements 2020
Declaration of Voting Results & Voting Rights Announcements
2020-11-27 English
Declaration of Voting Results & Voting Rights Announcements 2020
Declaration of Voting Results & Voting Rights Announcements
2020-11-26 English
Declaration of Voting Results & Voting Rights Announcements 2020
Declaration of Voting Results & Voting Rights Announcements
2020-11-24 English
Declaration of Voting Results & Voting Rights Announcements 2020
Declaration of Voting Results & Voting Rights Announcements
2020-11-23 English
Q3 statement / Q3 financial report 2020
Interim / Quarterly Report 9M 2020
2020-11-19 English
Declaration of Voting Results & Voting Rights Announcements 2020
Declaration of Voting Results & Voting Rights Announcements
2020-11-18 English
MorphoSys Reports Nine Months and Third Quarter 2020 Results
Earnings Release 9M 2020
2020-11-11 English
MorphoSys and Cherry Biolabs Announce licensing of Hemibody Technology
M&A Activity
2020-11-11 English
Xencor, MorphoSys and Incyte Enter into Global Development Collaboration for Tafasitamab in Combination with Plamotamab
Regulatory Filings
2020-11-11 English
Declaration of Voting Results & Voting Rights Announcements 2020
Declaration of Voting Results & Voting Rights Announcements
2020-11-06 English
Declaration of Voting Results & Voting Rights Announcements 2020
Declaration of Voting Results & Voting Rights Announcements
2020-11-06 English
Declaration of Voting Results & Voting Rights Announcements 2020
Declaration of Voting Results & Voting Rights Announcements
2020-11-05 English
Declaration of Voting Results & Voting Rights Announcements 2020
Declaration of Voting Results & Voting Rights Announcements
2020-11-05 English
Declaration of Voting Results & Voting Rights Announcements 2020
Declaration of Voting Results & Voting Rights Announcements
2020-11-05 English
MorphoSys to Present Data on Tafasitamab at the ASH Virtual Annual Meeting and Exposition
Regulatory Filings
2020-11-04 English
Invitation to MorphoSys' Third Quarter and First 9-Month 2020 Results Conference Call on November 12, 2020
Regulatory Filings
2020-11-04 English
Declaration of Voting Results & Voting Rights Announcements 2020
Declaration of Voting Results & Voting Rights Announcements
2020-10-30 English
Declaration of Voting Results & Voting Rights Announcements 2020
Declaration of Voting Results & Voting Rights Announcements
2020-10-28 English
Ad hoc: MorphoSys AG Raises its Financial Guidance for the Full Year 2020
Earnings Release 9M 2020
2020-10-27 English
MorphoSys' Licensee Janssen Receives CHMP Positive Opinion for Tremfya(R) (guselkumab) for Treatment of Adults with Active Psoriatic Arthritis (PsA) in the European Union (EU)
Regulatory Filings
2020-10-19 English
Declaration of Voting Results & Voting Rights Announcements 2020
Declaration of Voting Results & Voting Rights Announcements
2020-10-16 English
MorphoSys AG Successfully Places EUR 325 Million Convertible Bonds
Capital/Financing Update
2020-10-13 English
Ad hoc: MorphoSys AG Launches an Offering of approx. EUR 325 Million Convertible Bonds
Capital/Financing Update
2020-10-13 English
Declaration of Voting Results & Voting Rights Announcements 2020
Declaration of Voting Results & Voting Rights Announcements
2020-10-09 English
DGAP-DD: MorphoSys AG english
Director's Dealing
2020-10-06 English
DGAP-DD: MorphoSys AG english
Director's Dealing
2020-10-06 English
Declaration of Voting Results & Voting Rights Announcements 2020
Declaration of Voting Results & Voting Rights Announcements
2020-10-01 English
MorphoSys Announces Departure of Jens Holstein, CFO, by Year End 2020 (news with additional features)
Board/Management Information
2020-09-30 English
Declaration of Voting Results & Voting Rights Announcements 2020
Declaration of Voting Results & Voting Rights Announcements
2020-09-24 English
Declaration of Voting Results & Voting Rights Announcements 2020
Declaration of Voting Results & Voting Rights Announcements
2020-09-22 English
MorphoSys and Incyte to Host Investor Event to Discuss the Unmet Need and Global Opportunities for Tafasitamab in Non-Hodgkin Lymphomas (news with additional features)
Report Publication Announcement
2020-09-17 English
MorphoSys and I-Mab Announce FDA Clearance of IND Application for MOR210/TJ210 in Patients with Advanced Cancer (news with additional features)
Regulatory Filings
2020-09-17 English
Declaration of Voting Results & Voting Rights Announcements 2020
Declaration of Voting Results & Voting Rights Announcements
2020-09-16 English
Declaration of Voting Results & Voting Rights Announcements 2020
Declaration of Voting Results & Voting Rights Announcements
2020-09-14 English
Declaration of Voting Results & Voting Rights Announcements 2020
Declaration of Voting Results & Voting Rights Announcements
2020-09-07 English
Declaration of Voting Results & Voting Rights Announcements 2020
Declaration of Voting Results & Voting Rights Announcements
2020-08-26 English
National Comprehensive Cancer Network(R) Adds Monjuvi(R) (tafasitamab-cxix) to its Clinical Practice Guidelines in Oncology for B-cell Lymphomas
Regulatory Filings
2020-08-18 English
Declaration of Voting Results & Voting Rights Announcements 2020
Declaration of Voting Results & Voting Rights Announcements
2020-08-18 English
Declaration of Voting Results & Voting Rights Announcements 2020
Declaration of Voting Results & Voting Rights Announcements
2020-08-17 English
Declaration of Voting Results & Voting Rights Announcements 2020
Declaration of Voting Results & Voting Rights Announcements
2020-08-13 English
Declaration of Voting Results & Voting Rights Announcements 2020
Declaration of Voting Results & Voting Rights Announcements
2020-08-12 English
Declaration of Voting Results & Voting Rights Announcements 2020
Declaration of Voting Results & Voting Rights Announcements
2020-08-11 English
Half-yearly financial report 2020
Interim / Quarterly Report H2 2020
2020-08-11 English
Declaration of Voting Results & Voting Rights Announcements 2020
Declaration of Voting Results & Voting Rights Announcements
2020-08-07 English
Declaration of Voting Results & Voting Rights Announcements 2020
Declaration of Voting Results & Voting Rights Announcements
2020-08-07 English
MorphoSys Reports Second Quarter and First Half 2020 Results
Earnings Release H1 2020
2020-08-05 English
Declaration of Voting Results & Voting Rights Announcements 2020
Declaration of Voting Results & Voting Rights Announcements
2020-08-03 English
FDA Approves Monjuvi(R) (tafasitamab-cxix) in Combination with Lenalidomide for the Treatment of Adult Patients with Relapsed or Refractory Diffuse Large B-cell Lymphoma (DLBCL)
Regulatory Filings
2020-08-01 English
MorphoSys AG: Ad hoc: FDA Approves Monjuvi(R) (tafasitamab-cxix) in Combination with Lenalidomide for the Treatment of Adult Patients with Relapsed or Refractory Diffuse Large B-cell Lymphoma (DLBCL)
Legal Proceedings Report
2020-08-01 English
Declaration of Voting Results & Voting Rights Announcements 2020
Declaration of Voting Results & Voting Rights Announcements
2020-07-31 English
Invitation to MorphoSys' Second Quarter and First Half 2020 Results Conference Call on August 6, 2020
Report Publication Announcement
2020-07-30 English
MorphoSys' Licensee Janssen Announces Approval of Tremfya (Guselkumab) by U.S. FDA for Treatment of Adults with Active Psoriatic Arthritis
Regulatory Filings
2020-07-14 English
Declaration of Voting Results & Voting Rights Announcements 2020
Declaration of Voting Results & Voting Rights Announcements
2020-07-14 English
Declaration of Voting Results & Voting Rights Announcements 2020
Declaration of Voting Results & Voting Rights Announcements
2020-07-07 English
Declaration of Voting Results & Voting Rights Announcements 2020
Declaration of Voting Results & Voting Rights Announcements
2020-07-02 English
Declaration of Voting Results & Voting Rights Announcements 2020
Declaration of Voting Results & Voting Rights Announcements
2020-07-02 English
Declaration of Voting Results & Voting Rights Announcements 2020
Declaration of Voting Results & Voting Rights Announcements
2020-06-26 English
Declaration of Voting Results & Voting Rights Announcements 2020
Declaration of Voting Results & Voting Rights Announcements
2020-06-25 English
Declaration of Voting Results & Voting Rights Announcements 2020
Declaration of Voting Results & Voting Rights Announcements
2020-06-24 English
Declaration of Voting Results & Voting Rights Announcements 2020
Declaration of Voting Results & Voting Rights Announcements
2020-06-22 English
Declaration of Voting Results & Voting Rights Announcements 2020
Declaration of Voting Results & Voting Rights Announcements
2020-06-18 English
Declaration of Voting Results & Voting Rights Announcements 2020
Declaration of Voting Results & Voting Rights Announcements
2020-06-18 English
Declaration of Voting Results & Voting Rights Announcements 2020
Declaration of Voting Results & Voting Rights Announcements
2020-06-15 English
Declaration of Voting Results & Voting Rights Announcements 2020
Declaration of Voting Results & Voting Rights Announcements
2020-06-15 English
Declaration of Voting Results & Voting Rights Announcements 2020
Declaration of Voting Results & Voting Rights Announcements
2020-06-09 English
Declaration of Voting Results & Voting Rights Announcements 2020
Declaration of Voting Results & Voting Rights Announcements
2020-06-09 English
Declaration of Voting Results & Voting Rights Announcements 2020
Declaration of Voting Results & Voting Rights Announcements
2020-06-09 English
Declaration of Voting Results & Voting Rights Announcements 2020
Declaration of Voting Results & Voting Rights Announcements
2020-06-05 English
Declaration of Voting Results & Voting Rights Announcements 2020
Declaration of Voting Results & Voting Rights Announcements
2020-06-04 English
MorphoSys to Present at Upcoming Virtual Investor Conferences (news with additional features)
Report Publication Announcement
2020-06-02 English
Declaration of Voting Results & Voting Rights Announcements 2020
Declaration of Voting Results & Voting Rights Announcements
2020-05-28 English
Declaration of Voting Results & Voting Rights Announcements 2020
Declaration of Voting Results & Voting Rights Announcements
2020-05-28 English
MorphoSys AG Reports Outcome of Annual General Meeting 2020 (news with additional features)
AGM Information
2020-05-27 English
MorphoSys and Incyte Announce the Validation of the European Marketing Authorization Application for Tafasitamab (news with additional features)
Regulatory Filings
2020-05-20 English
MorphoSys to Present Data on Tafasitamab at the ASCO and EHA Virtual Meetings (news with additional features)
Environmental & Social Information
2020-05-14 English
MorphoSys and Incyte Announce Long-term Follow-up Results from L-MIND Study of Tafasitamab in Patients with r/r DLBCL (news with additional features)
Regulatory Filings
2020-05-14 English
Q1 statement / Q1 financial report 2020
Interim / Quarterly Report Q1 2020
2020-05-13 English
Declaration of Voting Results & Voting Rights Announcements 2020
Declaration of Voting Results & Voting Rights Announcements
2020-05-07 English
MorphoSys Reports First Quarter 2020 Results (news with additional features)
Earnings Release Q1 2020
2020-05-06 English
Declaration of Voting Results & Voting Rights Announcements 2020
Declaration of Voting Results & Voting Rights Announcements
2020-05-05 English
Declaration of Voting Results & Voting Rights Announcements 2020
Declaration of Voting Results & Voting Rights Announcements
2020-05-05 English
Declaration of Voting Results & Voting Rights Announcements 2020
Declaration of Voting Results & Voting Rights Announcements
2020-05-04 English
Invitation to MorphoSys' First Quarter 2020 Results Conference Call on May 7, 2020 (news with additional features)
Report Publication Announcement
2020-04-30 English
Declaration of Voting Results & Voting Rights Announcements 2020
Declaration of Voting Results & Voting Rights Announcements
2020-04-30 English
Declaration of Voting Results & Voting Rights Announcements 2020
Declaration of Voting Results & Voting Rights Announcements
2020-04-29 English
Declaration of Voting Results & Voting Rights Announcements 2020
Declaration of Voting Results & Voting Rights Announcements
2020-04-28 English
MorphoSys and I-Mab Announce First Patient Dosed in Phase 3 Clinical Trial of MOR202/TJ202 in r/r Multiple Myeloma in Mainland ChinaMorphoSys AG: (news with additional features)
Regulatory Filings
2020-04-27 English
Declaration of Voting Results & Voting Rights Announcements 2020
Declaration of Voting Results & Voting Rights Announcements
2020-04-23 English
DGAP-DD: MorphoSys AG english
Director's Dealing
2020-04-22 English
MorphoSys Appoints Roland Wandeler, Ph.D., as Chief Commercial Officer (news with additional features)
Board/Management Information
2020-04-21 English
Declaration of Voting Results & Voting Rights Announcements 2020
Declaration of Voting Results & Voting Rights Announcements
2020-04-21 English
MorphoSys AG: Bekanntmachung der Einberufung zur Hauptversammlung am 27.05.2020 in Munchen mit dem Ziel der europaweiten Verbreitung gema 121 AktG
AGM Information
2020-04-20 German
Declaration of Voting Results & Voting Rights Announcements 2020
Declaration of Voting Results & Voting Rights Announcements
2020-04-17 English
MorphoSys Provides Update on Impact of COVID-19 on Business Operations and Precautionary Measures (news with additional features)
Regulatory Filings
2020-04-06 English
Declaration of Voting Results & Voting Rights Announcements 2020
Declaration of Voting Results & Voting Rights Announcements
2020-03-27 English
Annual financial report 2019
Annual Report FY 2019
2020-03-26 German
Declaration of Voting Results & Voting Rights Announcements 2020
Declaration of Voting Results & Voting Rights Announcements
2020-03-23 English
Declaration of Voting Results & Voting Rights Announcements 2020
Declaration of Voting Results & Voting Rights Announcements
2020-03-19 English
MorphoSys Presents Results for Fiscal Year 2019 (news with additional features)
Earnings Release FY 2019
2020-03-18 English
Release according to Article 41 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
Declaration of Voting Results & Voting Rights Announcements
2020-03-13 English
Invitation to MorphoSys' Year-End Results 2019 Conference Call on March 19, 2020 (news with additional features)
Report Publication Announcement
2020-03-12 English
Declaration of Voting Results & Voting Rights Announcements 2020
Declaration of Voting Results & Voting Rights Announcements
2020-03-05 English
MorphoSys Resolves a Capital Increase to Implement the Purchase of 3,629,764 American Depositary Shares by Incyte Corporation (news with additional features)
Share Issue/Capital Change
2020-03-04 English
MorphoSys and Incyte Announce Antitrust Clearance of Global Collaboration and License Agreement for Tafasitamab (news with additional features)
M&A Activity
2020-03-03 English
Declaration of Voting Results & Voting Rights Announcements 2020
Declaration of Voting Results & Voting Rights Announcements
2020-03-03 English
FDA Accepts MorphoSys' Biologics License Application (BLA) and Grants Priority Review for Tafasitamab and Lenalidomide for the Treatment of Relapsed/Refractory DLBCL (news with additional features)
Regulatory Filings
2020-03-02 English
MorphoSys Initiates Expanded Access Program for Tafasitamab in the U.S. (news with additional features)
Legal Proceedings Report
2020-02-04 English
Release according to Article 41 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
Declaration of Voting Results & Voting Rights Announcements
2020-01-31 English
MorphoSys and Incyte Sign Global Collaboration and License Agreement for Tafasitamab (news with additional features)
M&A Activity
2020-01-13 English
MorphoSys AG: Ad hoc: MorphoSys and Incyte Sign Global Collaboration and License Agreement, including U.S. Co-Commercialization and Ex-U.S. Commercialization Rights, for Tafasitamab
M&A Activity
2020-01-13 English